Skip to main content
Top
Published in: Critical Care 1/2016

Open Access 01-12-2016 | Review

Individualizing endpoints in randomized clinical trials to better inform individual patient care: the TARGET proposal

Authors: Theodore J. Iwashyna, Adam M. Deane

Published in: Critical Care | Issue 1/2016

Login to get access

Abstract

In practice, critical care practitioners individualize treatments and goals of care for each patient in light of that patient’s acute and chronic pathophysiology, as well as their beliefs and values. Yet critical care researchers routinely measure one endpoint for all patients during randomized clinical trials (RCTs), eschewing any such individualization. More recent methodology work has explored the possibility that enrollment criteria in RCTs can be individualized, as can data analysis plans. Here we propose that the specific endpoints of a RCT can be individualized—that is, different patients within a single RCT might have different secondary endpoints measured. If done rigorously and objectively, based on pre-randomization data, such individualization of endpoints may improve the bedside usefulness of information obtained during a RCT, while perhaps also improving the power and efficiency of any RCT. We discuss the theoretical underpinnings of this proposal in light of related innovations in RCT design such as sliding dichotomies. We discuss what a full elaboration of such individualization would require, and outline a pragmatic initial step towards the use of “individualized secondary endpoints” in a large RCT evaluating optimal enteral nutrition targets in the critically ill.
Literature
1.
go back to reference Summers MJ, Chapple L-AS, McClave SA, Deane AM. Event-rate and delta inflation when evaluating mortality asa primary outcome from randomizd controlled trials of nutritional interventions during critical illness: a systematic review. Am J Clin Nutr. 2016; 103:in press. Summers MJ, Chapple L-AS, McClave SA, Deane AM. Event-rate and delta inflation when evaluating mortality asa primary outcome from randomizd controlled trials of nutritional interventions during critical illness: a systematic review. Am J Clin Nutr. 2016; 103:in press.
2.
go back to reference Harhay MO, Wagner J, Ratcliffe SJ, et al. Outcomes and statistical power in adult critical care randomized trials. Am J Respir Crit Care Med. 2014;189:1469–78.CrossRefPubMedPubMedCentral Harhay MO, Wagner J, Ratcliffe SJ, et al. Outcomes and statistical power in adult critical care randomized trials. Am J Respir Crit Care Med. 2014;189:1469–78.CrossRefPubMedPubMedCentral
3.
go back to reference Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346:1061–6.CrossRefPubMed Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346:1061–6.CrossRefPubMed
4.
go back to reference White DB, Engelberg RA, Wenrich MD, Lo B, Curtis JR. Prognostication during physician-family discussions about limiting life support in intensive care units. Crit Care Med. 2007;35:442–8.CrossRefPubMed White DB, Engelberg RA, Wenrich MD, Lo B, Curtis JR. Prognostication during physician-family discussions about limiting life support in intensive care units. Crit Care Med. 2007;35:442–8.CrossRefPubMed
5.
go back to reference Schwarze ML, Campbell TC, Cunningham TV, White DB, Arnold RM. You can’t get what you want: innovation for end-of-life communication in the intensive care unit. Am J Respir Crit Care Med. 2016;193:14–6.CrossRefPubMed Schwarze ML, Campbell TC, Cunningham TV, White DB, Arnold RM. You can’t get what you want: innovation for end-of-life communication in the intensive care unit. Am J Respir Crit Care Med. 2016;193:14–6.CrossRefPubMed
6.
go back to reference Nichol A, French C, Little L, et al. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial. Lancet. 2015;386:2499–506.CrossRefPubMed Nichol A, French C, Little L, et al. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial. Lancet. 2015;386:2499–506.CrossRefPubMed
7.
go back to reference Murray GD, Barer D, Choi S, et al. Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy. J Neurotrauma. 2005;22:511–7.CrossRefPubMed Murray GD, Barer D, Choi S, et al. Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy. J Neurotrauma. 2005;22:511–7.CrossRefPubMed
8.
go back to reference Skolnick BE, Maas AI, Narayan RK, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371:2467–76.CrossRefPubMed Skolnick BE, Maas AI, Narayan RK, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371:2467–76.CrossRefPubMed
9.
go back to reference Rosenbaum PR. The consequence of adjustment for a concomitant variable that has been affected by the treatment. J R Stat Soc Series A. 1984;147:656–66.CrossRef Rosenbaum PR. The consequence of adjustment for a concomitant variable that has been affected by the treatment. J R Stat Soc Series A. 1984;147:656–66.CrossRef
10.
go back to reference Price M, Hertzberg V, Wright DW. Does the sliding dichotomy result in higher powered clinical trials for stroke and traumatic brain injury research? Clin Trials. 2013;10:924–34.CrossRefPubMed Price M, Hertzberg V, Wright DW. Does the sliding dichotomy result in higher powered clinical trials for stroke and traumatic brain injury research? Clin Trials. 2013;10:924–34.CrossRefPubMed
11.
go back to reference Preneill JJ. Analysis of outcomes following severe trauamtic brain injury. Melbourne: University of Melbourne; 2007. Preneill JJ. Analysis of outcomes following severe trauamtic brain injury. Melbourne: University of Melbourne; 2007.
12.
go back to reference Prescott HC, Calfee CS, Thompson BT, Angus DC, Liu V. Towards smarter lumping and smarter splitting: rethinking strategies for sepsis and ARDS clinical trial design. Am J Respir Crit Care Med. 2016. [Epub ahead of print]. Prescott HC, Calfee CS, Thompson BT, Angus DC, Liu V. Towards smarter lumping and smarter splitting: rethinking strategies for sepsis and ARDS clinical trial design. Am J Respir Crit Care Med. 2016. [Epub ahead of print].
13.
go back to reference Goligher EC, Kavanagh BP, Rubenfeld GD, Ferguson ND. Physiologic responsiveness should guide entry into randomized controlled trials. Am J Respir Crit Care Med. 2015;192:1416–9.CrossRefPubMed Goligher EC, Kavanagh BP, Rubenfeld GD, Ferguson ND. Physiologic responsiveness should guide entry into randomized controlled trials. Am J Respir Crit Care Med. 2015;192:1416–9.CrossRefPubMed
16.
go back to reference Panacek EA, Marshall JC, Albertson TE, et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med. 2004;32:2173–82.CrossRefPubMed Panacek EA, Marshall JC, Albertson TE, et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med. 2004;32:2173–82.CrossRefPubMed
17.
go back to reference Rothwell PM, Warlow CP. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists’ Collaborative Group. Lancet. 1999;353:2105–10.CrossRefPubMed Rothwell PM, Warlow CP. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists’ Collaborative Group. Lancet. 1999;353:2105–10.CrossRefPubMed
18.
go back to reference Ioannidis JP, Lau J. The impact of high-risk patients on the results of clinical trials. J Clin Epidemiol. 1997;50:1089–98.CrossRefPubMed Ioannidis JP, Lau J. The impact of high-risk patients on the results of clinical trials. J Clin Epidemiol. 1997;50:1089–98.CrossRefPubMed
19.
go back to reference Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:85.CrossRefPubMedPubMedCentral Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:85.CrossRefPubMedPubMedCentral
20.
go back to reference Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007;298:1209–12.CrossRefPubMed Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007;298:1209–12.CrossRefPubMed
21.
go back to reference Iwashyna TJ, Burke JF, Sussman JB, Prescott HC, Hayward RA, Angus DC. Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care. Am J Respir Crit Care Med. 2015;192:1045–51.CrossRefPubMed Iwashyna TJ, Burke JF, Sussman JB, Prescott HC, Hayward RA, Angus DC. Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care. Am J Respir Crit Care Med. 2015;192:1045–51.CrossRefPubMed
22.
go back to reference Cohen DG, Christie JD, Anderson BJ, et al. Cognitive function, mental health, and health-related quality of life after lung transplantation. Ann Am Thorac Soc. 2014;11:522–30.CrossRefPubMedPubMedCentral Cohen DG, Christie JD, Anderson BJ, et al. Cognitive function, mental health, and health-related quality of life after lung transplantation. Ann Am Thorac Soc. 2014;11:522–30.CrossRefPubMedPubMedCentral
23.
go back to reference Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996. Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
24.
go back to reference Peake SL, Davies AR, Deane AM, et al. Use of a concentrated enteral nutrition solution to increase calorie delivery to critically ill patients: a randomized, double-blind, clinical trial. Am J Clin Nutr. 2014;100:616–25.CrossRefPubMed Peake SL, Davies AR, Deane AM, et al. Use of a concentrated enteral nutrition solution to increase calorie delivery to critically ill patients: a randomized, double-blind, clinical trial. Am J Clin Nutr. 2014;100:616–25.CrossRefPubMed
25.
go back to reference Freedman VA, Kasper JD, Cornman JC, et al. Validation of new measures of disability and functioning in the National Health and Aging Trends Study. J Gerontol A Biol Sci Med Sci. 2011;66:1013–21.CrossRefPubMed Freedman VA, Kasper JD, Cornman JC, et al. Validation of new measures of disability and functioning in the National Health and Aging Trends Study. J Gerontol A Biol Sci Med Sci. 2011;66:1013–21.CrossRefPubMed
26.
go back to reference Katz S, Ford AB, Moskowitz AW, Jackson BA, Jaffe MW. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–9.CrossRefPubMed Katz S, Ford AB, Moskowitz AW, Jackson BA, Jaffe MW. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–9.CrossRefPubMed
27.
go back to reference Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.CrossRefPubMed Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.CrossRefPubMed
28.
go back to reference Sackett DL. Why randomized controlled trials fail but needn’t: 2. Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!). CMAJ. 2001;165:1226–37.PubMedPubMedCentral Sackett DL. Why randomized controlled trials fail but needn’t: 2. Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!). CMAJ. 2001;165:1226–37.PubMedPubMedCentral
30.
go back to reference Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.CrossRefPubMed Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.CrossRefPubMed
31.
go back to reference Lim WC, Black N, Lamping D, Rowan K, Mays N. Conceptualizing and measuring health-related quality of life in critical care. J Crit Care. 2016;31:183–93.CrossRefPubMed Lim WC, Black N, Lamping D, Rowan K, Mays N. Conceptualizing and measuring health-related quality of life in critical care. J Crit Care. 2016;31:183–93.CrossRefPubMed
32.
go back to reference Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63:1179–94.CrossRefPubMedPubMedCentral Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63:1179–94.CrossRefPubMedPubMedCentral
33.
go back to reference Smith DM, Loewenstein G, Jankovic A, Ubel PA. Happily hopeless: adaptation to a permanent, but not to a temporary disability. Health Psychol. 2009;28:787–91.CrossRefPubMedPubMedCentral Smith DM, Loewenstein G, Jankovic A, Ubel PA. Happily hopeless: adaptation to a permanent, but not to a temporary disability. Health Psychol. 2009;28:787–91.CrossRefPubMedPubMedCentral
34.
go back to reference Fisher GG, Franks MM, Plassman BL, et al. Caring for individuals with dementia and cognitive impairment, not dementia: findings from the aging, demographics, and memory study. J Am Geriatr Soc. 2011;59:488–94.CrossRefPubMedPubMedCentral Fisher GG, Franks MM, Plassman BL, et al. Caring for individuals with dementia and cognitive impairment, not dementia: findings from the aging, demographics, and memory study. J Am Geriatr Soc. 2011;59:488–94.CrossRefPubMedPubMedCentral
Metadata
Title
Individualizing endpoints in randomized clinical trials to better inform individual patient care: the TARGET proposal
Authors
Theodore J. Iwashyna
Adam M. Deane
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2016
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-016-1388-0

Other articles of this Issue 1/2016

Critical Care 1/2016 Go to the issue